intismeran autogene
AssetAlso V940, mRNA-4157
Encodes individualized tumor neoantigens to stimulate tumor-specific T-cell immune responses.
- Stage
- Human trials
- Modality
- mRNA
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Melanoma
Human trials, businesswire.com, 7 Oct 2026
Other cancers
Human trials, businesswire.com, 7 Oct 2026
In the full profile
- Owner and partners2
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.